Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

计划入组 170 人 · 首次发布于 2023 年 12 月 15 日

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

计划入组 168 人 · 首次发布于 2024 年 5 月 20 日

Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray

计划入组 50 人 · 首次发布于 2014 年 5 月 7 日

Binaotong Nasal Spray

Bupleurum nasal spray

Carbetocin(Duratocin)

C₄₅H₆₉N₁₁O₁₂S · Rx

OCEAN SPRAY CRANBERRIES, INC.

United States

VistaGen Therapeutics

United States

Firebrick Pharma Ltd

Acadia Pharmaceuticals Launches Phase 3 COMPASS PWS Trial for Carbetocin Nasal Spray in Prader-Willi Syndrome

Acadia Pharmaceuticals' Phase 3 Trial Investigates Carbetocin Nasal Spray for Hyperphagia in Prader-Willi Syndrome

Experimental Nasal Spray PCANS Shows Promise Against Broad Range of Respiratory Viruses